TrustCore Financial Services’s Clover Health Investments CLOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
$74 Sell
80
-140
-64% -$187 ﹤0.01% 1020
2022
Q3
$0 Hold
220
﹤0.01% 1067
2022
Q2
$0 Sell
220
-100
-31% -$266 ﹤0.01% 1044
2022
Q1
$1K Hold
320
﹤0.01% 984
2021
Q4
$1K Hold
320
﹤0.01% 900
2021
Q3
$2K Buy
320
+60
+23% +$513 ﹤0.01% 942
2021
Q2
$3K Sell
260
-408
-61% -$4.01K ﹤0.01% 890
2021
Q1
$5K Buy
668
+396
+146% +$4.47K ﹤0.01% 784
2020
Q4
$5K Buy
+272
New +$3.03K ﹤0.01% 762

Other funds holding CLOV

TrustCore Financial Services's CLOV Position: Q4 2022 in Review

TrustCore Financial Services reduced its Clover Health Investments (CLOV) stake by 64% in Q4 2022, selling an estimated $187 and leaving 80 shares worth $74. The position accounts for ﹤0.01% of the portfolio, ranked #1020.

TrustCore Financial Services first reported a position in CLOV in Q4 2020 and has held it in 9 quarters since. The position peaked at $5K in Q1 2021. 174 funds tracked by Wall St. Rank hold CLOV as of Q4 2022.

  • TrustCore Financial Services held 80 shares of Clover Health Investments worth $74 as of Q4 2022.
  • TrustCore Financial Services sold 140 Clover Health Investments shares in Q4 2022, an estimated $187.
  • Clover Health Investments made up ﹤0.01% of TrustCore Financial Services's portfolio in Q4 2022, its #1020 holding.
  • TrustCore Financial Services first reported a position in Clover Health Investments in Q4 2020 and has held it in 9 quarters since.
  • TrustCore Financial Services's Clover Health Investments position peaked at $5K in Q1 2021.
  • 174 funds tracked by Wall St. Rank held Clover Health Investments as of Q4 2022.

Based on TrustCore Financial Services's 13F filing for Q4 2022, filed 13 Feb 2023.